Skip to content
DataLookout
Menu

PIE-eMMsNCT06999928

Enhanced Mentor Mother Strategy for Pregnant and Postpartum Women Living With HIV

StatusCompleted
PhaseNot applicable
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 5 versions: 4 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 9 words Show 7 more changesShow less
    • Primary endpoints: details revised at 1 of 3 entries
    • Trial completed
    • Final enrollment: 116 participants (planned 200)
    • Primary and study completion dates changed from estimate of Oct 12, 2026 to Oct 23, 2026
    • Secondary endpoints: details revised at 1 of 7 entries
    • Site details revised
    • Study description expanded, about 2 words
  2. Minor Start date changed from estimate of Jul 14, 2025 to Jul 10, 2025v3
  3. Notable Start date: Jun 2, 2025 to Jul 14, 2025
    • Primary and study completion dates: Sep 1, 2026 to Oct 12, 2026
    v2
  4. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Fidelity: Proportion of enhanced Mentor Mother strategy tasks completed and services correctly assigned/delivered, as assessed by checklists, audits, and observations.
Timeframe: Fidelity to the enhanced MM strategy will be assessed throughout the 15-month implementation period, and a process of audit and feedback will be used to enhance fidelity and further refine the strategy.
Acceptability: Participant ratings of acceptability of the enhanced Mentor Mother strategy, assessed by AIM scores, satisfaction surveys, and focus group discussions.
Timeframe: Acceptability of the enhanced MM strategy will be assessed at the end of the 15-month implementation period.
Feasibility: Participant ratings of feasibility of the enhanced Mentor Mother strategy, assessed by FIM scores and focus group discussions.
Timeframe: Feasibility of the enhanced MM strategy will be assessed at the end of the 15-month implementation period.

Secondary (7)

Proportion of mothers retained in care
Proportion of mothers with HIV viral suppression
Proportion of mothers who died
Proportion of mothers who transferred out
Proportion of infants receiving HIV diagnostic testing
Show 2 moreShow less
Proportion of infants infected with HIV (vertical transmission)
Proportion of infants who died

Arms and interventions

Enhanced Mentor Mother StrategyExperimental

Participants will receive support from a Mentor Mother (MM) who delivers a risk-based, differentiated package of PMTCT services tailored to the needs of pregnant and postpartum women living with HIV (WLHIV). At each clinic visit, the MM will assess maternal and infant risk using a structured tool. Based on the result, the MM provides tailored support, such as counseling, navigation, linkage to resources, or increased follow-up. WLHIV without identified risks receive a streamlined support package. The strategy is integrated into routine antenatal and postnatal care at the study site.

Behavioral: Enhanced Mentor Mother Strategy

Sites

1 site in 1 country

  • Burnt Forest Sub-District HospitalBurnt Forest, Uasin Gishu County, Kenya